"Vaccinatiepunt Beverwijk is er voor al uw vaccinaties. Zowel reizigersvaccinaties als projectvaccinaties"

During the past decade, Rode Kruis Ziekenhuis conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 5 clinical trials were completed, i.e. on average, 16.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rode Kruis Ziekenhuis" #1 sponsor was "Association of Dutch Burn Centres" with 7 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "CUTISS AG" with 3 trials sponsored and "Dutch Colorectal Cancer Group" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rode Kruis Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 6 trials as a collaborator, "Borstkanker Onderzoek Groep" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Julius Clinical" with 3 trials as a collaborator and "Roche Pharma AG" with 3 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Rode Kruis Ziekenhuis" are "Burns" (7 trials), "Breast Cancer" (4 trials), "Appendicitis" (3 trials), "Heart Failure" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Rode Kruis Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Rode Kruis Ziekenhuis" are "Drug" (32 trials), "Procedure" (10 trials), "Other" (7 trials), "Biological" (4 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "EHSG-KF" (3 trials), "STSG" (3 trials), "Apixaban" (2 trials) and "Appendectomy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rode Kruis Ziekenhuis" are 51 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Rode Kruis Ziekenhuis". undefined are not yet recruiting, 14 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Rode Kruis Ziekenhuis, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Rode Kruis Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 10 trials that are defined as “Not Applicable".